My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

6.720 +0.420 (+6.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

August 22, 2023

Via ACCESSWIRE

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

August 01, 2023

Via ACCESSWIRE

Champions Oncology Earnings Perspective: Return On Capital Employed ↗

July 25, 2023

Via Benzinga

Champions Oncology Reports Quarterly Revenue of $13.1 Million

July 24, 2023

Via ACCESSWIRE

Champions Oncology's Earnings: A Preview ↗

July 21, 2023

Via Benzinga

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

July 20, 2023

Via ACCESSWIRE

Champions Oncology's Earnings: A Preview ↗

March 14, 2023

Via Benzinga

Champions Oncology's Return On Capital Employed Insights ↗

December 30, 2022

Via Benzinga

Champions Oncology Reports Quarterly Revenue of $12.9 Million

July 21, 2022

Via ACCESSWIRE

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

April 17, 2023

Via ACCESSWIRE

Champions Oncology Announces $5M Stock Repurchase Program

April 05, 2023

Via ACCESSWIRE

$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying ↗

March 22, 2023

The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Champions Oncology Reports Quarterly Revenue of $12.8 Million

March 15, 2023

Via ACCESSWIRE

Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023

March 13, 2023

Via ACCESSWIRE

Earnings Scheduled For March 15, 2023 ↗

March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

Via Benzinga

Analyzing Champions Oncology's Short Interest ↗

December 15, 2022

Champions Oncology's (NASDAQ:CSBR) short percent of float has risen 6.9% since its last report. The company recently reported that it has 64 thousand shares sold short, which is 0.93% of all regular...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 15, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 14, 2022

Via Benzinga

Champions Oncology Reports Record Quarterly Revenue of $14.3 Million

December 13, 2022

Via ACCESSWIRE

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022

December 09, 2022

Via ACCESSWIRE

Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday ↗

September 16, 2022

Gainers

Via Benzinga

Champions Oncology Reports Record Quarterly Revenue of $13.7 Million

September 08, 2022

Via ACCESSWIRE

Earnings Scheduled For September 8, 2022 ↗

September 08, 2022

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second...

Via Benzinga

Earnings Preview For Champions Oncology ↗

September 07, 2022

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022

September 06, 2022

Via ACCESSWIRE

Champions Oncology Reports Quarterly Revenue of $12.9 Million

July 21, 2022

Record Annual Revenue of $49.1 Million

From Champions Oncology, Inc.

Via AccessWire

Earnings Scheduled For July 21, 2022 ↗

July 21, 2022

Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.

Via Benzinga

A Preview Of Champions Oncology's Earnings ↗

July 20, 2022

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022

July 14, 2022

HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...

From Champions Oncology, Inc.

Via AccessWire

Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics

May 31, 2022

HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative...

From Champions Oncology, Inc.

Via AccessWire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.